511 related articles for article (PubMed ID: 30505434)
1. One-year molecular surveillance of carbapenem-susceptible
Wendel AF; Malecki M; Otchwemah R; Tellez-Castillo CJ; Sakka SG; Mattner F
Antimicrob Resist Infect Control; 2018; 7():145. PubMed ID: 30505434
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
3. Endemic carbapenem-nonsusceptible
Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
[TBL] [Abstract][Full Text] [Related]
4. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
Martins N; Martins IS; de Freitas WV; de Matos JA; Girão VB; Coelho-Souza T; Maralhães AC; Cacci LC; de Figueiredo MP; Dias RC; Costa-Lourenço AP; Ferreira AL; Dalla-Costa L; Nouér SA; Santoro-Lopes G; Riley LW; Moreira BM
Microb Drug Resist; 2013 Jun; 19(3):216-23. PubMed ID: 23336529
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological investigation of an Acinetobacter baumannii outbreak using core genome multilocus sequence typing.
Venditti C; Vulcano A; D'Arezzo S; Gruber CEM; Selleri M; Antonini M; Lanini S; Marani A; Puro V; Nisii C; Di Caro A
J Glob Antimicrob Resist; 2019 Jun; 17():245-249. PubMed ID: 30553929
[TBL] [Abstract][Full Text] [Related]
6. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center.
De Vos D; Pirnay JP; Bilocq F; Jennes S; Verbeken G; Rose T; Keersebilck E; Bosmans P; Pieters T; Hing M; Heuninckx W; De Pauw F; Soentjens P; Merabishvili M; Deschaght P; Vaneechoutte M; Bogaerts P; Glupczynski Y; Pot B; van der Reijden TJ; Dijkshoorn L
PLoS One; 2016; 11(5):e0156237. PubMed ID: 27223476
[TBL] [Abstract][Full Text] [Related]
8. The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.
Ghaith DM; Zafer MM; Al-Agamy MH; Alyamani EJ; Booq RY; Almoazzamy O
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):34. PubMed ID: 28486994
[TBL] [Abstract][Full Text] [Related]
9. Clonal spread of carbapenem-resistant Acinetobacter baumannii across a community hospital and its affiliated long-term care facilities: A cross sectional study.
Chen CH; Kuo HY; Hsu PJ; Chang CM; Chen JY; Lu HH; Chen HY; Liou ML
J Microbiol Immunol Infect; 2018 Jun; 51(3):377-384. PubMed ID: 28826855
[TBL] [Abstract][Full Text] [Related]
10. High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study.
Chen Y; Yang Y; Liu L; Qiu G; Han X; Tian S; Zhao J; Chen F; Grundmann H; Li H; Sun J; Han L
BMC Infect Dis; 2018 Sep; 18(1):491. PubMed ID: 30268099
[TBL] [Abstract][Full Text] [Related]
11. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
El Bannah AMS; Nawar NN; Hassan RMM; Salem STB
Microb Drug Resist; 2018 Apr; 24(3):269-277. PubMed ID: 28783427
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
14. Emergence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii strains of clonal complexes 103(B) and 92(B) harboring OXA-type carbapenemases and metallo-β-lactamases in Southern India.
Saranathan R; Vasanth V; Vasanth T; Shabareesh PR; Shashikala P; Devi CS; Kalaivani R; Asir J; Sudhakar P; Prashanth K
Microbiol Immunol; 2015 May; 59(5):277-84. PubMed ID: 25726848
[TBL] [Abstract][Full Text] [Related]
15. Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA).
Rao J; Susanti D; Childress JC; Mitkos MC; Brima JK; Baffoe-Bonnie AW; Pearce SN; Grgurich D; Fernandez-Cotarelo MJ; Kerkering TM; Mukhopadhyay B
J Glob Antimicrob Resist; 2018 Mar; 12():79-87. PubMed ID: 28899807
[TBL] [Abstract][Full Text] [Related]
16. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.
Irfan S; Turton JF; Mehraj J; Siddiqui SZ; Haider S; Zafar A; Memon B; Afzal O; Hasan R
J Hosp Infect; 2011 Jun; 78(2):143-8. PubMed ID: 21459477
[TBL] [Abstract][Full Text] [Related]
17. Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
Rieber H; Frontzek A; Pfeifer Y
Microb Drug Resist; 2017 Jan; 23(1):25-31. PubMed ID: 27093111
[TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.
Chen T; Fu Y; Hua X; Xu Q; Lan P; Jiang Y; Yu Y; Zhou Z
Int J Antimicrob Agents; 2021 Oct; 58(4):106404. PubMed ID: 34298091
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
Kouyama Y; Harada S; Ishii Y; Saga T; Yoshizumi A; Tateda K; Yamaguchi K
J Infect Chemother; 2012 Aug; 18(4):522-8. PubMed ID: 22327516
[TBL] [Abstract][Full Text] [Related]
20. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.
Kohlenberg A; Brümmer S; Higgins PG; Sohr D; Piening BC; de Grahl C; Halle E; Rüden H; Seifert H
J Med Microbiol; 2009 Nov; 58(Pt 11):1499-1507. PubMed ID: 19589905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
